APO Research
Talk to an analyst

APO RESEARCH · REPORT

PD-1 and PD-L1 Inhibitors

PD-1 inhibitors and PD-L1 inhibitors are a group of checkpoint inhibitors being developed for the treatment of cancer. PD-1 and PD-L1 are both proteins present on the surface of cells. Immune checkpoint inhibitors such as these are emerging as a front-line treatment for several types of cancer.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

PD-1 inhibitors and PD-L1 inhibitors are a group of checkpoint inhibitors being developed for the treatment of cancer. PD-1 and PD-L1 are both proteins present on the surface of cells. Immune checkpoint inhibitors such as these are emerging as a front-line treatment for several types of cancer.

Selected research

Industry Growth & Trends

Global PD-1 and PD-L1 Inhibitors Industry Growth and Trends Forecast to 2032

30 December 2025102 pages

Choose your research edition.

Industry ResearchPD-1 and PD-L1 Inhibitors Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal PD-1 and PD-L1 Inhibitors Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal PD-1 and PD-L1 Inhibitors Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal PD-1 and PD-L1 Inhibitors Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal PD-1 and PD-L1 Inhibitors Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

PD-1 inhibitors and PD-L1 inhibitors are a group of checkpoint inhibitors being developed for the treatment of cancer. PD-1 and PD-L1 are both proteins present on the surface of cells. Immune checkpoint inhibitors such as these are emerging as a front-line treatment for several types of cancer.

North America is the largest consumption place, with a consumption market share nearly 60.40% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 20.66%.Market competition is intense. Merck, Bristol-Myers Squibb, Roche, AstraZeneca, Ono Pharmaceutical etc. are the leaders of the industry.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global PD-1 and PD-L1 Inhibitors market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The PD-1 and PD-L1 Inhibitors market size, estimates, and forecasts are presented in terms of sales volume (L) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global PD-1 and PD-L1 Inhibitors market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to PD-1 and PD-L1 Inhibitors.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global PD-1 and PD-L1 Inhibitors market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

PD-1 and PD-L1 Inhibitors Market by Company

Merck

Bristol-Myers Squibb

Roche

AstraZeneca

Ono Pharmaceutical

Regeneron

Innovent

Hengrui Medicine

Junshi Biosciences

Merck KGaA

PD-1 and PD-L1 Inhibitors Segment by Type

PD-1 Inhibitors

PD-L1 Inhibitors

PD-1 and PD-L1 Inhibitors Segment by Application

Solid Tumors

Blood-related Tumors

PD-1 and PD-L1 Inhibitors Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PD-1 and PD-L1 Inhibitors market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of PD-1 and PD-L1 Inhibitors and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PD-1 and PD-L1 Inhibitors.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of PD-1 and PD-L1 Inhibitors manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of PD-1 and PD-L1 Inhibitors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of PD-1 Inhibitors Table 2. Major Company of PD-L1 Inhibitors Table 3. Global PD-1 and PD-L1 Inhibitors Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global PD-1 and PD-L1 Inhibitors Sales by Type (2021-2026) & (L) Table 5. Global PD-1 and PD-L1 Inhibitors Sales Market Share in Volume by Type (2021-2026) Table 6. Global PD-1 and PD-L1 Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 7. Global PD-1 and PD-L1 Inhibitors Sales Market Share in Value by Type (2021-2026) Table 8. Global PD-1 and PD-L1 Inhibitors Price by Type (2021-2026) & (USD/ml) Table 9. Global PD-1 and PD-L1 Inhibitors Sales by Type (2027-2032) & (L) Table 10. Global PD-1 and PD-L1 Inhibitors Sales Market Share in Volume by Type (2027-2032) Table 11. Global PD-1 and PD-L1 Inhibitors Sales by Type (2027-2032) & (US$ Million) Table 12. Global PD-1 and PD-L1 Inhibitors Sales Market Share in Value by Type (2027-2032) Table 13. Global PD-1 and PD-L1 Inhibitors Price by Type (2027-2032) & (USD/ml) Table 14. North America PD-1 and PD-L1 Inhibitors Sales by Type (2021-2026) & (L) Table 15. North America PD-1 and PD-L1 Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 16. Europe PD-1 and PD-L1 Inhibitors Sales by Type (2021-2026) & (L) Table 17. Europe PD-1 and PD-L1 Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales by Type (2021-2026) & (L) Table 19. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America PD-1 and PD-L1 Inhibitors Sales by Type (2021-2026) & (L) Table 21. Latin America PD-1 and PD-L1 Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales by Type (2021-2026) & (L) Table 23. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 24. PD-1 and PD-L1 Inhibitors Industry Trends Table 25. PD-1 and PD-L1 Inhibitors Industry Drivers Table 26. PD-1 and PD-L1 Inhibitors Industry Opportunities and Challenges Table 27. PD-1 and PD-L1 Inhibitors Industry Restraints Table 28. Global PD-1 and PD-L1 Inhibitors Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Company (2021-2026) Table 30. Global PD-1 and PD-L1 Inhibitors Sales by Company (2021-2026) & (L) Table 31. Global PD-1 and PD-L1 Inhibitors Sales Share by Company (2021-2026) Table 32. Global PD-1 and PD-L1 Inhibitors Market Price by Company (2021-2026) & (USD/ml) Table 33. Global PD-1 and PD-L1 Inhibitors Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global PD-1 and PD-L1 Inhibitors Major Company Production Sites and Headquarters Table 35. Global PD-1 and PD-L1 Inhibitors Company, Product Type & Application Table 36. Global PD-1 and PD-L1 Inhibitors Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global PD-1 and PD-L1 Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global PD-1 and PD-L1 Inhibitors Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global PD-1 and PD-L1 Inhibitors Sales by Region (2021-2026) & (L) Table 41. Global PD-1 and PD-L1 Inhibitors Sales Market Share in Volume by Region (2021-2026) Table 42. Global PD-1 and PD-L1 Inhibitors Sales by Region (2021-2026) & (US$ Million) Table 43. Global PD-1 and PD-L1 Inhibitors Sales Market Share in Value by Region (2021-2026) Table 44. Global PD-1 and PD-L1 Inhibitors Sales (L), Value (US$ Million), Price (USD/ml) and Gross Margin (2021-2026) Table 45. Global PD-1 and PD-L1 Inhibitors Sales by Region (2027-2032) & (L) Table 46. Global PD-1 and PD-L1 Inhibitors Sales Market Share in Volume by Region (2027-2032) Table 47. Global PD-1 and PD-L1 Inhibitors Sales by Region (2027-2032) & (US$ Million) Table 48. Global PD-1 and PD-L1 Inhibitors Sales Market Share in Value by Region (2027-2032) Table 49. Global PD-1 and PD-L1 Inhibitors Sales (L), Value (US$ Million), Price (USD/ml) and Gross Margin (2027-2032) Table 50. Global PD-1 and PD-L1 Inhibitors Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global PD-1 and PD-L1 Inhibitors Sales by Application (2021-2026) & (L) Table 52. Global PD-1 and PD-L1 Inhibitors Sales Market Share in Volume by Application (2021-2026) Table 53. Global PD-1 and PD-L1 Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 54. Global PD-1 and PD-L1 Inhibitors Sales Market Share in Value by Application (2021-2026) Table 55. Global PD-1 and PD-L1 Inhibitors Price by Application (2021-2026) & (USD/ml) Table 56. Global PD-1 and PD-L1 Inhibitors Sales by Application (2027-2032) & (L) Table 57. Global PD-1 and PD-L1 Inhibitors Sales Market Share in Volume by Application (2027-2032) Table 58. Global PD-1 and PD-L1 Inhibitors Sales by Application (2027-2032) & (US$ Million) Table 59. Global PD-1 and PD-L1 Inhibitors Sales Market Share in Value by Application (2027-2032) Table 60. Global PD-1 and PD-L1 Inhibitors Price by Application (2027-2032) & (USD/ml) Table 61. North America PD-1 and PD-L1 Inhibitors Sales by Application (2021-2026) & (L) Table 62. North America PD-1 and PD-L1 Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 63. Europe PD-1 and PD-L1 Inhibitors Sales by Application (2021-2026) & (L) Table 64. Europe PD-1 and PD-L1 Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales by Application (2021-2026) & (L) Table 66. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America PD-1 and PD-L1 Inhibitors Sales by Application (2021-2026) & (L) Table 68. Latin America PD-1 and PD-L1 Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales by Application (2021-2026) & (L) Table 70. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 71. Merck Company Information Table 72. Merck Business Overview Table 73. Merck PD-1 and PD-L1 Inhibitors Sales (L), Revenue (US$ Million), Price (USD/ml) and Gross Margin (2021-2026) Table 74. Merck PD-1 and PD-L1 Inhibitors Product Portfolio Table 75. Merck Recent Development Table 76. Bristol-Myers Squibb Company Information Table 77. Bristol-Myers Squibb Business Overview Table 78. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Sales (L), Revenue (US$ Million), Price (USD/ml) and Gross Margin (2021-2026) Table 79. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Product Portfolio Table 80. Bristol-Myers Squibb Recent Development Table 81. Roche Company Information Table 82. Roche Business Overview Table 83. Roche PD-1 and PD-L1 Inhibitors Sales (L), Revenue (US$ Million), Price (USD/ml) and Gross Margin (2021-2026) Table 84. Roche PD-1 and PD-L1 Inhibitors Product Portfolio Table 85. Roche Recent Development Table 86. AstraZeneca Company Information Table 87. AstraZeneca Business Overview Table 88. AstraZeneca PD-1 and PD-L1 Inhibitors Sales (L), Revenue (US$ Million), Price (USD/ml) and Gross Margin (2021-2026) Table 89. AstraZeneca PD-1 and PD-L1 Inhibitors Product Portfolio Table 90. AstraZeneca Recent Development Table 91. Ono Pharmaceutical Company Information Table 92. Ono Pharmaceutical Business Overview Table 93. Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Sales (L), Revenue (US$ Million), Price (USD/ml) and Gross Margin (2021-2026) Table 94. Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Product Portfolio Table 95. Ono Pharmaceutical Recent Development Table 96. Regeneron Company Information Table 97. Regeneron Business Overview Table 98. Regeneron PD-1 and PD-L1 Inhibitors Sales (L), Revenue (US$ Million), Price (USD/ml) and Gross Margin (2021-2026) Table 99. Regeneron PD-1 and PD-L1 Inhibitors Product Portfolio Table 100. Regeneron Recent Development Table 101. Innovent Company Information Table 102. Innovent Business Overview Table 103. Innovent PD-1 and PD-L1 Inhibitors Sales (L), Revenue (US$ Million), Price (USD/ml) and Gross Margin (2021-2026) Table 104. Innovent PD-1 and PD-L1 Inhibitors Product Portfolio Table 105. Innovent Recent Development Table 106. Hengrui Medicine Company Information Table 107. Hengrui Medicine Business Overview Table 108. Hengrui Medicine PD-1 and PD-L1 Inhibitors Sales (L), Revenue (US$ Million), Price (USD/ml) and Gross Margin (2021-2026) Table 109. Hengrui Medicine PD-1 and PD-L1 Inhibitors Product Portfolio Table 110. Hengrui Medicine Recent Development Table 111. Junshi Biosciences Company Information Table 112. Junshi Biosciences Business Overview Table 113. Junshi Biosciences PD-1 and PD-L1 Inhibitors Sales (L), Revenue (US$ Million), Price (USD/ml) and Gross Margin (2021-2026) Table 114. Junshi Biosciences PD-1 and PD-L1 Inhibitors Product Portfolio Table 115. Junshi Biosciences Recent Development Table 116. Merck KGaA Company Information Table 117. Merck KGaA Business Overview Table 118. Merck KGaA PD-1 and PD-L1 Inhibitors Sales (L), Revenue (US$ Million), Price (USD/ml) and Gross Margin (2021-2026) Table 119. Merck KGaA PD-1 and PD-L1 Inhibitors Product Portfolio Table 120. Merck KGaA Recent Development Table 121. North America PD-1 and PD-L1 Inhibitors Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 122. North America PD-1 and PD-L1 Inhibitors Sales by Country (2021-2026) & (L) Table 123. North America PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2021-2026) Table 124. North America PD-1 and PD-L1 Inhibitors Sales Forecast by Country (2027-2032) & (L) Table 125. North America PD-1 and PD-L1 Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 126. North America PD-1 and PD-L1 Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America PD-1 and PD-L1 Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 128. North America PD-1 and PD-L1 Inhibitors Market Share by Country (2021-2026) Table 129. North America PD-1 and PD-L1 Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America PD-1 and PD-L1 Inhibitors Market Share Forecast by Country (2027-2032) Table 131. Europe PD-1 and PD-L1 Inhibitors Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 132. Europe PD-1 and PD-L1 Inhibitors Sales by Country (2021-2026) & (L) Table 133. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2021-2026) Table 134. Europe PD-1 and PD-L1 Inhibitors Sales Forecast by Country (2027-2032) & (L) Table 135. Europe PD-1 and PD-L1 Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 136. Europe PD-1 and PD-L1 Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe PD-1 and PD-L1 Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe PD-1 and PD-L1 Inhibitors Market Share by Country (2021-2026) Table 139. Europe PD-1 and PD-L1 Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe PD-1 and PD-L1 Inhibitors Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific PD-1 and PD-L1 Inhibitors Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales by Country (2021-2026) & (L) Table 143. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales Forecast by Country (2027-2032) & (L) Table 145. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific PD-1 and PD-L1 Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific PD-1 and PD-L1 Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific PD-1 and PD-L1 Inhibitors Market Share by Country (2021-2026) Table 149. Asia-Pacific PD-1 and PD-L1 Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific PD-1 and PD-L1 Inhibitors Market Share Forecast by Country (2027-2032) Table 151. Latin America PD-1 and PD-L1 Inhibitors Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 152. Latin America PD-1 and PD-L1 Inhibitors Sales by Country (2021-2026) & (L) Table 153. Latin America PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2021-2026) Table 154. Latin America PD-1 and PD-L1 Inhibitors Sales Forecast by Country (2027-2032) & (L) Table 155. Latin America PD-1 and PD-L1 Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America PD-1 and PD-L1 Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America PD-1 and PD-L1 Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America PD-1 and PD-L1 Inhibitors Market Share by Country (2021-2026) Table 159. Latin America PD-1 and PD-L1 Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America PD-1 and PD-L1 Inhibitors Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa PD-1 and PD-L1 Inhibitors Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales by Country (2021-2026) & (L) Table 163. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales Forecast by Country (2027-2032) & (L) Table 165. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa PD-1 and PD-L1 Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa PD-1 and PD-L1 Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa PD-1 and PD-L1 Inhibitors Market Share by Country (2021-2026) Table 169. Middle East and Africa PD-1 and PD-L1 Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa PD-1 and PD-L1 Inhibitors Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. PD-1 and PD-L1 Inhibitors Distributors List Table 174. PD-1 and PD-L1 Inhibitors Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. PD-1 and PD-L1 Inhibitors Image Figure 2. Global PD-1 and PD-L1 Inhibitors Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global PD-1 and PD-L1 Inhibitors Market Size (2021-2032) & (US$ Million) Figure 4. Global PD-1 and PD-L1 Inhibitors Sales (2021-2032) & (L) Figure 5. PD-1 Inhibitors Image Figure 6. Global PD-1 Inhibitors Sales YoY Growth (2021-2032) & (L) Figure 7. PD-L1 Inhibitors Image Figure 8. Global PD-L1 Inhibitors Sales YoY Growth (2021-2032) & (L) Figure 9. Global PD-1 and PD-L1 Inhibitors Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global PD-1 and PD-L1 Inhibitors Market Share by Type 2025 VS 2032 Figure 11. North America PD-1 and PD-L1 Inhibitors Sales Market Share in Volume by Type in 2025 Figure 12. North America PD-1 and PD-L1 Inhibitors Sales Market Share in Value by Type in 2025 Figure 13. Europe PD-1 and PD-L1 Inhibitors Sales Market Share in Volume by Type in 2025 Figure 14. Europe PD-1 and PD-L1 Inhibitors Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales Market Share in Value by Type in 2025 Figure 17. Latin America PD-1 and PD-L1 Inhibitors Sales Market Share in Volume by Type in 2025 Figure 18. Latin America PD-1 and PD-L1 Inhibitors Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 PD-1 and PD-L1 Inhibitors Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Solid Tumors Image Figure 24. Global Solid Tumors Sales YoY Growth (2021-2032) & (L) Figure 25. Blood-related Tumors Image Figure 26. Global Blood-related Tumors Sales YoY Growth (2021-2032) & (L) Figure 27. Global PD-1 and PD-L1 Inhibitors Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global PD-1 and PD-L1 Inhibitors Market Share by Application 2025 VS 2032 Figure 29. North America PD-1 and PD-L1 Inhibitors Sales Market Share in Volume by Application in 2025 Figure 30. North America PD-1 and PD-L1 Inhibitors Sales Market Share in Value by Application in 2025 Figure 31. Europe PD-1 and PD-L1 Inhibitors Sales Market Share in Volume by Application in 2025 Figure 32. Europe PD-1 and PD-L1 Inhibitors Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales Market Share in Value by Application in 2025 Figure 35. Latin America PD-1 and PD-L1 Inhibitors Sales Market Share in Volume by Application in 2025 Figure 36. Latin America PD-1 and PD-L1 Inhibitors Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales Market Share in Value by Application in 2025 Figure 39. North America PD-1 and PD-L1 Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 40. North America PD-1 and PD-L1 Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America PD-1 and PD-L1 Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America PD-1 and PD-L1 Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe PD-1 and PD-L1 Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 44. Europe PD-1 and PD-L1 Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe PD-1 and PD-L1 Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe PD-1 and PD-L1 Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 48. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific PD-1 and PD-L1 Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific PD-1 and PD-L1 Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America PD-1 and PD-L1 Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 52. Latin America PD-1 and PD-L1 Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America PD-1 and PD-L1 Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America PD-1 and PD-L1 Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 56. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa PD-1 and PD-L1 Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa PD-1 and PD-L1 Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. PD-1 and PD-L1 Inhibitors Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. PD-1 and PD-L1 Inhibitors Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • PD-1 Inhibitors
  • PD-L1 Inhibitors
Applications
  • Solid Tumors
  • Blood-related Tumors
Companies covered
  • Merck
  • Bristol-Myers Squibb
  • Roche
  • AstraZeneca
  • Ono Pharmaceutical
  • Regeneron
  • Innovent
  • Hengrui Medicine
  • Junshi Biosciences
  • Merck KGaA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global PD-1 and PD-L1 Inhibitors Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global PD-1 and PD-L1 Inhibitors Sales Estimates and Forecasts (2021-2032)
  5. 1.3 PD-1 and PD-L1 Inhibitors Market by Type
  6. 1.3.1 PD-1 Inhibitors
  7. 1.3.2 PD-L1 Inhibitors
  8. 1.4 Global PD-1 and PD-L1 Inhibitors Market Size by Type
  9. 1.4.1 Global PD-1 and PD-L1 Inhibitors Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global PD-1 and PD-L1 Inhibitors Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global PD-1 and PD-L1 Inhibitors Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America PD-1 and PD-L1 Inhibitors Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe PD-1 and PD-L1 Inhibitors Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific PD-1 and PD-L1 Inhibitors Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America PD-1 and PD-L1 Inhibitors Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa PD-1 and PD-L1 Inhibitors Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 PD-1 and PD-L1 Inhibitors Industry Trends
  2. 2.2 PD-1 and PD-L1 Inhibitors Industry Drivers
  3. 2.3 PD-1 and PD-L1 Inhibitors Industry Opportunities and Challenges
  4. 2.4 PD-1 and PD-L1 Inhibitors Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by PD-1 and PD-L1 Inhibitors Revenue (2021-2026)
  2. 3.2 Global Top Players by PD-1 and PD-L1 Inhibitors Sales (2021-2026)
  3. 3.3 Global Top Players by PD-1 and PD-L1 Inhibitors Price (2021-2026)
  4. 3.4 Global PD-1 and PD-L1 Inhibitors Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global PD-1 and PD-L1 Inhibitors Major Company Production Sites & Headquarters
  6. 3.6 Global PD-1 and PD-L1 Inhibitors Company, Product Type & Application
  7. 3.7 Global PD-1 and PD-L1 Inhibitors Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global PD-1 and PD-L1 Inhibitors Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 PD-1 and PD-L1 Inhibitors Players Market Share by Revenue in 2025
  11. 3.8.3 2025 PD-1 and PD-L1 Inhibitors Tier 1, Tier 2, and Tier 3
4 PD-1 and PD-L1 Inhibitors Regional Status and Outlook
  1. 4.1 Global PD-1 and PD-L1 Inhibitors Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global PD-1 and PD-L1 Inhibitors Historic Market Size by Region
  3. 4.2.1 Global PD-1 and PD-L1 Inhibitors Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global PD-1 and PD-L1 Inhibitors Sales in Value by Region (2021-2026)
  5. 4.2.3 Global PD-1 and PD-L1 Inhibitors Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global PD-1 and PD-L1 Inhibitors Forecasted Market Size by Region
  7. 4.3.1 Global PD-1 and PD-L1 Inhibitors Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global PD-1 and PD-L1 Inhibitors Sales in Value by Region (2027-2032)
  9. 4.3.3 Global PD-1 and PD-L1 Inhibitors Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 PD-1 and PD-L1 Inhibitors by Application
  1. 5.1 PD-1 and PD-L1 Inhibitors Market by Application
  2. 5.1.1 Solid Tumors
  3. 5.1.2 Blood-related Tumors
  4. 5.2 Global PD-1 and PD-L1 Inhibitors Market Size by Application
  5. 5.2.1 Global PD-1 and PD-L1 Inhibitors Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global PD-1 and PD-L1 Inhibitors Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global PD-1 and PD-L1 Inhibitors Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America PD-1 and PD-L1 Inhibitors Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe PD-1 and PD-L1 Inhibitors Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific PD-1 and PD-L1 Inhibitors Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America PD-1 and PD-L1 Inhibitors Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa PD-1 and PD-L1 Inhibitors Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merck
  2. 6.1.1 Merck Company Information
  3. 6.1.2 Merck Business Overview
  4. 6.1.3 Merck PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merck PD-1 and PD-L1 Inhibitors Product Portfolio
  6. 6.1.5 Merck Recent Developments
  7. 6.2 Bristol-Myers Squibb
  8. 6.2.1 Bristol-Myers Squibb Company Information
  9. 6.2.2 Bristol-Myers Squibb Business Overview
  10. 6.2.3 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Product Portfolio
  12. 6.2.5 Bristol-Myers Squibb Recent Developments
  13. 6.3 Roche
  14. 6.3.1 Roche Company Information
  15. 6.3.2 Roche Business Overview
  16. 6.3.3 Roche PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Roche PD-1 and PD-L1 Inhibitors Product Portfolio
  18. 6.3.5 Roche Recent Developments
  19. 6.4 AstraZeneca
  20. 6.4.1 AstraZeneca Company Information
  21. 6.4.2 AstraZeneca Business Overview
  22. 6.4.3 AstraZeneca PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 AstraZeneca PD-1 and PD-L1 Inhibitors Product Portfolio
  24. 6.4.5 AstraZeneca Recent Developments
  25. 6.5 Ono Pharmaceutical
  26. 6.5.1 Ono Pharmaceutical Company Information
  27. 6.5.2 Ono Pharmaceutical Business Overview
  28. 6.5.3 Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Product Portfolio
  30. 6.5.5 Ono Pharmaceutical Recent Developments
  31. 6.6 Regeneron
  32. 6.6.1 Regeneron Company Information
  33. 6.6.2 Regeneron Business Overview
  34. 6.6.3 Regeneron PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Regeneron PD-1 and PD-L1 Inhibitors Product Portfolio
  36. 6.6.5 Regeneron Recent Developments
  37. 6.7 Innovent
  38. 6.7.1 Innovent Company Information
  39. 6.7.2 Innovent Business Overview
  40. 6.7.3 Innovent PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Innovent PD-1 and PD-L1 Inhibitors Product Portfolio
  42. 6.7.5 Innovent Recent Developments
  43. 6.8 Hengrui Medicine
  44. 6.8.1 Hengrui Medicine Company Information
  45. 6.8.2 Hengrui Medicine Business Overview
  46. 6.8.3 Hengrui Medicine PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Hengrui Medicine PD-1 and PD-L1 Inhibitors Product Portfolio
  48. 6.8.5 Hengrui Medicine Recent Developments
  49. 6.9 Junshi Biosciences
  50. 6.9.1 Junshi Biosciences Company Information
  51. 6.9.2 Junshi Biosciences Business Overview
  52. 6.9.3 Junshi Biosciences PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Junshi Biosciences PD-1 and PD-L1 Inhibitors Product Portfolio
  54. 6.9.5 Junshi Biosciences Recent Developments
  55. 6.10 Merck KGaA
  56. 6.10.1 Merck KGaA Company Information
  57. 6.10.2 Merck KGaA Business Overview
  58. 6.10.3 Merck KGaA PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Merck KGaA PD-1 and PD-L1 Inhibitors Product Portfolio
  60. 6.10.5 Merck KGaA Recent Developments
7 North America by Country
  1. 7.1 North America PD-1 and PD-L1 Inhibitors Sales by Country
  2. 7.1.1 North America PD-1 and PD-L1 Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America PD-1 and PD-L1 Inhibitors Sales by Country (2021-2026)
  4. 7.1.3 North America PD-1 and PD-L1 Inhibitors Sales Forecast by Country (2027-2032)
  5. 7.2 North America PD-1 and PD-L1 Inhibitors Market Size by Country
  6. 7.2.1 North America PD-1 and PD-L1 Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America PD-1 and PD-L1 Inhibitors Market Size by Country (2021-2026)
  8. 7.2.3 North America PD-1 and PD-L1 Inhibitors Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe PD-1 and PD-L1 Inhibitors Sales by Country
  2. 8.1.1 Europe PD-1 and PD-L1 Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe PD-1 and PD-L1 Inhibitors Sales by Country (2021-2026)
  4. 8.1.3 Europe PD-1 and PD-L1 Inhibitors Sales Forecast by Country (2027-2032)
  5. 8.2 Europe PD-1 and PD-L1 Inhibitors Market Size by Country
  6. 8.2.1 Europe PD-1 and PD-L1 Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe PD-1 and PD-L1 Inhibitors Market Size by Country (2021-2026)
  8. 8.2.3 Europe PD-1 and PD-L1 Inhibitors Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific PD-1 and PD-L1 Inhibitors Sales by Country
  2. 9.1.1 Asia-Pacific PD-1 and PD-L1 Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific PD-1 and PD-L1 Inhibitors Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific PD-1 and PD-L1 Inhibitors Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific PD-1 and PD-L1 Inhibitors Market Size by Country
  6. 9.2.1 Asia-Pacific PD-1 and PD-L1 Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific PD-1 and PD-L1 Inhibitors Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific PD-1 and PD-L1 Inhibitors Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America PD-1 and PD-L1 Inhibitors Sales by Country
  2. 10.1.1 South America PD-1 and PD-L1 Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America PD-1 and PD-L1 Inhibitors Sales by Country (2021-2026)
  4. 10.1.3 South America PD-1 and PD-L1 Inhibitors Sales Forecast by Country (2027-2032)
  5. 10.2 South America PD-1 and PD-L1 Inhibitors Market Size by Country
  6. 10.2.1 South America PD-1 and PD-L1 Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America PD-1 and PD-L1 Inhibitors Market Size by Country (2021-2026)
  8. 10.2.3 South America PD-1 and PD-L1 Inhibitors Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa PD-1 and PD-L1 Inhibitors Sales by Country
  2. 11.1.1 Middle East and Africa PD-1 and PD-L1 Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa PD-1 and PD-L1 Inhibitors Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa PD-1 and PD-L1 Inhibitors Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa PD-1 and PD-L1 Inhibitors Market Size by Country
  6. 11.2.1 Middle East and Africa PD-1 and PD-L1 Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa PD-1 and PD-L1 Inhibitors Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa PD-1 and PD-L1 Inhibitors Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 PD-1 and PD-L1 Inhibitors Value Chain Analysis
  2. 12.1.1 PD-1 and PD-L1 Inhibitors Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 PD-1 and PD-L1 Inhibitors Production Mode & Process
  7. 12.2 PD-1 and PD-L1 Inhibitors Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 PD-1 and PD-L1 Inhibitors Distributors
  10. 12.2.3 PD-1 and PD-L1 Inhibitors Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst